ATAI Life Sciences NV (FRA:9VC) 3-Year EBITDA Growth Rate : 27.60% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV 3-Year EBITDA Growth Rate?

ATAI Life Sciences NV's EBITDA per Share for the three months ended in Mar. 2024 was €-0.14.

During the past 3 years, the average EBITDA Per Share Growth Rate was 27.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of ATAI Life Sciences NV was 27.60% per year. The lowest was -151.70% per year. And the median was -62.05% per year.

Competitive Comparison of ATAI Life Sciences NV's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, ATAI Life Sciences NV's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ATAI Life Sciences NV's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ATAI Life Sciences NV's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where ATAI Life Sciences NV's 3-Year EBITDA Growth Rate falls into.

ATAI Life Sciences NV 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

ATAI Life Sciences NV (FRA:9VC) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

ATAI Life Sciences NV 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of ATAI Life Sciences NV's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

ATAI Life Sciences NV (FRA:9VC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

ATAI:USA ATAI:Mexico

Address

Wallstraße 16, Berlin, BB, DEU, 10179

Website

https://www.atai.life

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

ATAI Life Sciences NV (FRA:9VC) Headlines

No Headlines